Shanghai MicroPort Endovascular MedTech Co., Ltd. announced a private placement of not more than 21,593,444 A shares for gross proceeds of not more than CNY 2,546,839,300 on July 25, 2022. The transaction will include participation form not more than 35 investors. The issuance price is not less than 80% of the average price in the 20 trading days before the pricing reference date. The shares cannot be transferred within 6 months from the issuance closing date. The transaction has been approved by the board of directors of the company at its 9th Meeting of the Company’s 2nd Directorate held on July 25, 2022, and is subject to the approvals of the Company’s Shareholders, the Shanghai Stock Exchange, and the China Securities Regulatory Commission.

The Company approved the 2022 private placement of A shares in the 9th Meeting of the 2nd Directorate and the 6th Meeting of the 2nd Supervisory Board.

On September 29, 2022, the company announced that the transaction has been approved by the shareholders at 2nd shareholders’ meeting for 2022.

On December 14, 2022, the company announced that the transaction has been approved by the 13th session of the company’s 2nd directorate.

On February 2, 2023, the company announced that the Shanghai Stock Exchange has accepted the application for the issuance of stocks and shares to specific objects.

On March 28, 2023, the company announced that the transaction has been approved by the 14th session of the company’s 2nd directorate.

On May 23, 2023, the company announced that the transaction has been approved by the 16th session of the company’s 2nd directorate.